Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
about
Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3Regulation of P-TEFb elongation complex activity by CDK9 acetylationThe carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic miceAvian erythroleukemia: a model for corepressor function in cancer.Chromosomal integration of retinoic acid response elements prevents cooperative transcriptional activation by retinoic acid receptor and retinoid X receptor.Nuclear receptor-dependent transcription with chromatin. Is it all about enzymes?The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what's genetics got to do with it?Association of v-ErbA with Smad4 disrupts TGF-beta signaling.Thyroid hormone receptor mutations found in renal clear cell carcinomas alter corepressor release and reveal helix 12 as key determinant of corepressor specificity.ProNGF Drives Localized and Cell Selective Parvalbumin Interneuron and Perineuronal Net Depletion in the Dentate Gyrus of Transgenic MiceIn vivo repression of an erythroid-specific gene by distinct corepressor complexes.DNA methylation immediately adjacent to active histone marking does not silence transcription.A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.Nuclear export of the oncoprotein v-ErbA is mediated by acquisition of a viral nuclear export sequence.Thyroid hormone receptor alpha1 directly controls transcription of the beta-catenin gene in intestinal epithelial cells.The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.
P2860
Q24599788-96C1F9F4-160E-499B-B473-2DF03B3C34BAQ24675988-76B05242-79E9-4041-9468-AAFE504E90B8Q30439216-A920610B-44AF-4338-9EF5-5F26CAC8F5A7Q30541267-F701EF11-28AB-4D7A-B6B9-5D43A92D9A6CQ34290292-160AE383-DAE5-4799-901A-1FB2054D788CQ34302232-62014886-09F4-4A02-B9D6-37672151EB94Q34621596-2291BA74-C499-4B7F-B828-BD8B80B76081Q36268324-18875C04-E242-4DEA-9F72-3496CBC32A06Q37112637-9C3E845F-7A2B-4702-8EB0-02DF27A07100Q37283621-FBEF2BD9-D5B0-40A3-89C8-2C1A4A17B93EQ37633907-D02A5511-2FA1-4F35-B801-A6D5F2BEAC77Q39644809-D19182EA-ACE1-40E0-8CDA-D43620BB94BBQ40187418-64277341-CF02-42CC-94BC-9609C6C6B064Q40860064-2FBD0428-0DDF-41E5-8300-A8A64B48F693Q42832229-27FBD5CC-6658-41FE-8700-C64DD6CFB7D2Q42942149-56D501E9-6B0C-4332-BE81-46BF81C03E5DQ43583402-0DA1C575-7878-43B2-82FD-599714E3F708
P2860
Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Leukemic transformation by the ...... an erythroid enhancer in vivo.
@en
Leukemic transformation by the ...... an erythroid enhancer in vivo.
@nl
type
label
Leukemic transformation by the ...... an erythroid enhancer in vivo.
@en
Leukemic transformation by the ...... an erythroid enhancer in vivo.
@nl
prefLabel
Leukemic transformation by the ...... an erythroid enhancer in vivo.
@en
Leukemic transformation by the ...... an erythroid enhancer in vivo.
@nl
P2093
P2860
P356
P1433
P1476
Leukemic transformation by the ...... an erythroid enhancer in vivo
@en
P2093
Barettino D
Braliou GG
Stunnenberg HG
von Lindern M
P2860
P304
P356
10.1093/EMBOJ/17.24.7382
P407
P50
P577
1998-12-01T00:00:00Z